Premature ejaculation is thought to be the most common male sexual disorder, with some data estimating that it affects as many as one in five men 18 to 59 years old.
A panel of four experts will provide an update on the latest treatment options for premature ejaculation during Sunday morning’s Prime Time plenary session. The 30-minute panel discussion begins at 8 am in the Esplanade Ballroom at Moscone South.
“There are treatments available that have provided some relief, and urologists need a periodic review of these treatments and a look into the future for what else they can expect,” said session moderator Drogo Montague, MD, professor of Surgery at Cleveland Clinic Lerner College of Medicine at Case Western Reserve University.
The discussion will open with a presentation by Daniel Shoskes, MD, MSc, FRCSC, professor of Urology at Cleveland Clinic, Director of The Center for Men’s Health and Director of The Novick Center for Clinical and Translational Research at the Glickman Urological and Kidney Institute. Dr. Shoskes will discuss the difference between lifelong premature ejaculation and acquired premature ejaculation. He will also discuss some of the theories behind the causes of premature ejaculation.
Tobias Kohler, MD, MPH, professor of Urology at Mayo Clinic, will discuss the pharmacologic management of premature ejaculation.
The AUA published guidelines on the management of premature ejaculation in 2004, and reviewed and validated the guidelines in 2010. The guidelines address treatment options, including the use of topical treatments.
“These treatments are creams that contain a local anesthetic to reduce sensitivity,” Dr. Montague said. “This might help delay ejaculation but by reducing sensitivity there’s an undesirable side effect.”
Other pharmacological strategies include antidepressants such as selective serotonin reuptake inhibitors (SSRIs).
“We have known for some time that when SSRIs are used to treat depression, men with good erection are often unable to reach good orgasm,” Dr. Montague said. “That’s how we got the idea to use SSRIs in non- depressed men in smaller doses, taken three to four hours before intercourse to delay ejaculation.”
Michael Perelman, PhD, Clinical Professor Emeritus of Psychology and former clinical professor of Reproductive Medicine and Urology at Weill Cornell Medicine, is a clinical psychologist who will discuss non-pharmacological treatments and behavior modifications that may help patients with premature ejaculation.
The session’s final presenter, Nelson Bennett Jr., MD, FACS, associate professor of Urology at Northwestern University Feinberg School of Medicine, will review emerging therapies and examine the future of the field.